Medical expert warns of long-term health risks from GLP-1 weight-loss drugs

Dr. Jack Mosley argues that Ozempic and Mounjaro, while effective for weight loss, pose significant long-term health risks if not paired with lifestyle interventions like diet and exercise. The claim highlights growing medical concern regarding the unsupervised or monotherapy use of GLP-1 receptor agonists.